Spire Healthcare GroupLSE:SPI +2.78%73 EBITDA Margin % is 15.43% as of Dec. 2025, which is 4% below its 10-year median of 16.07. GuruFocus rates LSE:SPI with a GF Score™ of 73/100 and a GF Value™ of £2.71 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Spire Healthcare Group ranks better than 62.43% on this metric.
Spire Healthcare Group (LSE:SPI) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Spire Healthcare Group EBITDA Margin % Related Terms
Spire Healthcare Group EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Spire Healthcare Group's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:SPI vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Spire Healthcare Group's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Spire Healthcare Group EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Spire Healthcare Group's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Spire Healthcare Group's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Spire Healthcare Group (LSE:SPI) has a EBITDA Margin % of 15.43% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Spire Healthcare Group and its competitors. This is near median its historical median of 16.07. According to the industry distribution chart, Spire Healthcare Group ranks #251 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 37.6%.
Is Spire Healthcare Group's EBITDA Margin % too high?
Spire Healthcare Group's current EBITDA Margin % of 15.43% is near median its 10-year median of 16.07. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Spire Healthcare Group's value of 15.43% is 51.1% above this industry median. Based on the distribution chart, Spire Healthcare Group ranks #251 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Spire Healthcare Group has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Spire Healthcare Group's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Spire Healthcare Group ranks #251 out of 668 companies for EBITDA Margin %. This puts Spire Healthcare Group in the upper half of its industry. The industry median EBITDA Margin % is 10.21. Spire Healthcare Group's value of 15.43% is 51.1% above this benchmark. While the company's 10-year median is 16.07 vs. the industry median of 10.21, Spire Healthcare Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Spire Healthcare Group's current EBITDA Margin % of 15.43% is 51.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Spire Healthcare Group and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Spire Healthcare Group's current EBITDA Margin % is 15.43%, which is near median its own 10-year median of 16.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spire Healthcare Group stock overvalued right now?
Based on GuruFocus' analysis, Spire Healthcare Group (LSE:SPI) is currently considered Modestly Undervalued. The stock's GF Value™ is £2.71, compared to a current price of £2.22 — trading 18.1% below its estimated fair value. The current EBITDA Margin % is 15.43%, which is near median its 10-year median of 16.07 and 51.1% above the Healthcare Providers & Services industry median of 10.21. Spire Healthcare Group's overall GF Score™ is 73/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Spire Healthcare Group (LSE:SPI), the current EBITDA Margin % is 15.43% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Spire Healthcare Group (LSE:SPI) Overvalued in 2026?
Based on GuruFocus' analysis, Spire Healthcare Group stock appears to be undervalued.
The current stock price of £2.22 is trading 18.1% below its estimated GF Value™ of £2.71.
GuruFocus considers Spire Healthcare Group to be Modestly Undervalued.
Key valuation signals for LSE:SPI:
EBITDA Margin %: 15.43% (near median its 10-year median of 16.07)
GF Value™: £2.71 vs. price of £2.22 (18.1% below fair value)
Industry Position: 51.1% above the Healthcare Providers & Services median (#251 of 668)
No single metric tells the full story. See the LSE:SPI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Spire Healthcare Group PLC is an independent hospital group in the United Kingdom. It is a private provider, by volume, of knee and hip operations in the United Kingdom. The company has two operating segments: the hospitals business and the Primary care. The company generates the majority of its revenue from Hospital Business, which consists of hospitals, clinics, medical centres and consulting rooms. The company provide diagnostics, inpatient, day case and outpatient care in areas including orthopaedics, gynaecology, cardiology, neurology, oncology and general surgery. The primary care segment encompasses services focused on the primary care needs of outpatients, including GP services, occupational health services or mental and physical health services.
73GF Score
Get the complete analysis for LSE:SPI
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:SPI has been successfully added to your 
